Investor Relations

SEC Filings

SEC Filings

Document Highlights
Other Filings
Filing Description Filing Type Filing Date Event Date Download
10-Q 10-Q 5/9/2019 3/31/2019
8-K 8-K 5/7/2019 5/7/2019
Abstract: 8-K filed by Evolent Health (EVH) covering Results of Operations and Financial Condition; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; and Financial Statements and Exhibits.
Proxy DEF 14A 4/30/2019 6/11/2019
Proxy DEFA14A 4/30/2019
8-K 8-K 4/23/2019 4/19/2019
Abstract: 8-K filed by Evolent Health (EVH) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
8-K 8-K 4/10/2019 4/10/2019
Abstract: 8-K filed by Evolent Health (EVH) covering Changes in Registrant's Certifying Accountant and Financial Statements and Exhibits.
8-K 8-K 3/28/2019 3/28/2019
Abstract: 8-K filed by Evolent Health (EVH) covering Unregistered Sales of Equity Securities; Regulation FD Disclosure; and Financial Statements and Exhibits.
10-K 10-K 2/28/2019 12/31/2018
8-K 8-K 2/26/2019 2/26/2019
Abstract: 8-K filed by Evolent Health (EVH) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 2/8/2019 2/6/2019
Abstract: On Feb. 6, registrant reported the date of its 2019 annual meeting of shareholders.
Annual Report AR 12/31/2018
10-Q 10-Q 11/8/2018 9/30/2018
8-K 8-K 11/6/2018 11/6/2018
Abstract: 8-K filed by Evolent Health (EVH) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 10/24/2018 10/24/2018
Abstract: 8-K filed by Evolent Health (EVH) covering Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Unregistered Sales of Equity Securities; and Financial Statements and Exhibits.
8-K 8-K 10/23/2018 10/22/2018
Abstract: 8-K filed by Evolent Health (EVH) covering Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Unregistered Sales of Equity Securities; and Financial Statements and Exhibits.
8-K 8-K 10/18/2018 10/17/2018
Abstract: On Oct. 17, registrant announced the pricing of $150.0 million aggregate principal amount of 1.50% convertible senior notes due 2025.
8-K 8-K 10/16/2018 10/16/2018
Abstract: On Oct. 16, registrant announced its intention to offer $125.0 million aggregate principal amount of convertible senior notes due 2025.
8-K 8-K 10/2/2018 10/1/2018
Abstract: 8-K filed by Evolent Health (EVH) covering Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; Regulation FD Disclosure; and Financial Statements and Exhibits.
8-K 8-K 9/12/2018 9/7/2018
Abstract: 8-K filed by Evolent Health (EVH) covering Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Disclosure; and Financial Statements and Exhibits.
10-Q 10-Q 8/9/2018 6/30/2018

Displaying 1 to 20 (of 119 filings)
  • 1